Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer

A. Romero Falcon, A. Montes Worboys, L. Gomez Izquierdo, A. Casas, J. Martin, C. Navarro, I. De Torres, F. Rodriguez-Panadero (Seville, Spain)

Source: Annual Congress 2005 - What's new in the pleura
Session: What's new in the pleura
Session type: Oral Presentation
Number: 4474
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Romero Falcon, A. Montes Worboys, L. Gomez Izquierdo, A. Casas, J. Martin, C. Navarro, I. De Torres, F. Rodriguez-Panadero (Seville, Spain). Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer. Eur Respir J 2005; 26: Suppl. 49, 4474

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Epidemiology and clinical problems of orphant pleural adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Survival of lung adenocarcinoma patients with malignant pleural effusion
Source: Eur Respir J 2013; 41: 1409-1418
Year: 2013



Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007

Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009


Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM)
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020


Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Is pleural VEGF a useful parameter?
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007


Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast carcinoma
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Black pleural effusion as the presenting feature of lung cancer.
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018

Ultra-late pleural metastasis of breast cancer: are they so rare?
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007

Tumor-derived tumor necrosis factor-α promotes Lewis lung cancer-induced malignant pleural effusions in mice
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006